What are Pancreatic Beta Cells? 

The importance of beta cells in regenerative medicine

Beta cells are important in regenerative medicine because the loss or dysfunction of these cells is a hallmark of diabetes. Regenerative medicine seeks to develop treatments that can replace or regenerate damaged or diseased tissues and organs, and beta cell replacement therapies are an area of active research in this field.

One promising approach to beta cell replacement involves the use of stem cells, which have the ability to differentiate into many different cell types, including beta cells. Researchers are working to develop methods to generate beta cells from stem cells in the lab, with the goal of producing a reliable and unlimited source of beta cells for future therapies.

In addition to replacement therapies, regenerative medicine approaches to beta cell regeneration seek to stimulate the body’s own mechanisms for repairing and regenerating beta cells. Researchers are investigating the use of growth factors and other signaling molecules to promote beta cell growth and regeneration, with the goal of developing therapies that can stimulate beta cell regeneration in patients with diabetes.

What are beta cells? 

Pancreatic beta cells produce, store, and release insulin in order to regulate blood glucose levels. Beta cells (sometimes written as β-cells) are located in the pancreatic endocrine structures called the islets of Langerhans.   

Diabetes mellitus is one of the most prevalent metabolic disorders, occurring due to the loss or impaired function of insulin-secreting pancreatic beta cells by the immune system. While insulin is a life-saving treatment, in order to cure diabetes, destroyed beta cells must be replaced in the body. Islet cell transplantation from cadaveric pancreatic tissue has shown to be effective, but severely restricted by the supply of islet tissue available and other complications.   

Stem cell-derived cell therapy is a very promising option for diabetes treatment. Induced pluripotent stem cell (iPSC) can provide an unlimited source of pancreatic cells with the capacity to secrete insulin in response to high blood glucose level. Recent breakthroughs in pancreatic differentiation and scale-up protocols have led to early clinical trials transplanting stem cell-derived pancreatic cells to patients to restore their ability to regulate their blood glucose levels. 

How are beta cells used in research applications? 

Beta cells are used in a variety of research applications to study the biology and pathology of diabetes, as well as to develop new treatments for the disease. Here are a few examples:

1. Disease modeling: Beta cells are used to create models of diabetes in the lab. Researchers can use these models to study the underlying mechanisms of the disease and to test new therapies.
2. Drug screening: Beta cells can be used in high-throughput drug screening assays to identify new compounds that may be effective in treating diabetes. Researchers can test thousands of compounds on beta cells in a relatively short period of time to identify potential drug candidates.
3. Islet transplantation: Researchers can use beta cells or islets of Langerhans to study islet transplantation, a potential treatment for diabetes. Transplantation studies can help to optimize the transplantation procedure and to identify factors that may improve the survival and function of transplanted beta cells.
4. Beta cell regeneration: Beta cells can be used to study the mechanisms of beta cell regeneration and to develop strategies for promoting beta cell regeneration in patients with diabetes.
5. Genomics: Beta cells can be used in genomics studies to identify genes and pathways that are involved in the development and function of beta cells. This information can be used to develop new therapies and to identify patients who may benefit from specific treatments.

Overall, beta cells are an important tool in diabetes research, and they are used in a variety of applications to understand the disease and to develop new treatments.

Examples of diabetes research groups

• National Institutes of Health (NIH): The NIH is a part of the U.S. Department of Health and Human Services and is the largest biomedical research agency in the world. The NIH funds and conducts research on diabetes, including studies on the biology of the disease, prevention, and treatment.
• Harvard Stem Cell Institute (Diabetes Program) led by Doug Melton and Stephan Kissler, has a long-standing history of stem cell research, developing many diverse technologies and treatments in regenerative medicine and cell-based therapies. 
• University of Miami Diabetes Research Institute leads the world in cure-focused diabetes research. As one of the largest and most comprehensive research centers dedicated to curing diabetes, the DRI is aggressively working to develop a biological cure for diabetes by restoring natural insulin production and normalizing blood sugar levels without imposing other risks.
• American Diabetes Association (ADA): The ADA is a nonprofit organization that funds diabetes research and provides education and support to people with diabetes. The organization funds research through its Research Foundation, which has invested more than $860 million in diabetes research since 1952.
• JDRF (formerly the Juvenile Diabetes Research Foundation) is a nonprofit organization that funds research to find a cure for type 1 diabetes and improve the lives of people with the disease. The organization has invested more than $2.5 billion in diabetes research since its founding in 1970.
• International Diabetes Federation (IDF): The IDF is a global leader of diabetes associations that works to promote diabetes care, prevention, and a cure worldwide. The organization funds research and advocacy initiatives to raise awareness about diabetes and to improve access to care for people with the disease.

Image source: Stem cell-derived beta cells made by the Douglas Melton lab and provided for educational purposes only.